Literature DB >> 23428457

Laboratory findings in neurosyphilis patients with epileptic seizures alone as the initial presenting symptom.

Man-Li Tong1, Li-Li Liu, Yan-Li Zeng, Hui-Lin Zhang, Gui-Li Liu, Wei-Hong Zheng, Jie Dong, Jing-Yi Wu, Yuan-Hui Su, Li-Rong Lin, Tian-Ci Yang.   

Abstract

A retrospective chart review was performed to characterize the clinical presentation, the characteristic combination of serologic and cerebrospinal fluid (CSF) abnormalities, and the neuroimaging findings of neurosyphilis (NS) patients who had epileptic seizures alone as an initial presenting symptom. In a 6.75-year period, 169 inpatients with NS were identified at Zhongshan Hospital (from June 2005 to February 2012). We demonstrated that 13 (7.7%) of the 169 NS patients had epileptic seizures alone as an initial presenting feature. Epileptic seizures occurred in NS patients with syphilitic meningitis (2 cases), meningovascular NS (5 cases), and general paresis (6 cases). The types of epileptic seizures included simple partial, complex partial with secondary generalization (including status epilepticus), and generalized seizures (no focal onset reported). Nine of NS patients with only epileptic seizures as primary symptom were misdiagnosed, and the original misdiagnosis was 69.23% (9/13). Ten (10/13, 76.9%) patients had an abnormal magnetic resonance imaging, and 7 (7/13 53.8%) patients had abnormal electroencephalogram recordings. In addition, the sera rapid plasma reagin (RPR) and Treponema pallidum particle agglutination (TPPA) from all 13 patients were positive. The overall positive rates of the CSF-RPR and CSF-TPPA were 61.5% and 69.2%, respectively. Three patients demonstrated CSF pleocytosis, and 9 patients exhibited elevated CSF protein levels. Therefore, NS with only epileptic seizures at the initial presentation exhibits a lack of specificity. It is recommended that every patient with clinically evident symptoms of epileptic seizures should have a blood test performed for syphilis. When the serology results are positive, all of the patients should undergo a CSF examination to diagnose NS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428457     DOI: 10.1016/j.diagmicrobio.2013.01.013

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  4 in total

1.  Ceftriaxone compared with penicillin G for the treatment of neurosyphilis: study protocol for a multicenter randomized controlled trial.

Authors:  Fang-Zhi Du; Min-Zhi Wu; Xu Zhang; Rui-Li Zhang; Qian-Qiu Wang
Journal:  Trials       Date:  2022-10-01       Impact factor: 2.728

2.  Epilepsy and syphilis: A systematic review and meta-analysis.

Authors:  Chao Zhang; Wei Yue; Shuping Hou; Wanzhen Cui; Lei Xiang
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

3.  Diagnostic tools for neurosyphilis: a systematic review.

Authors:  Gustavo Henrique Pereira Boog; João Vitor Ziroldo Lopes; João Vitor Mahler; Marina Solti; Lucas Tokio Kawahara; Andre Kakinoki Teng; João Victor Taba Munhoz; Anna S Levin
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

4.  CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.

Authors:  Yan-Li Zeng; Yi-Qiang Lin; Ning-Ning Zhang; Chao-Ning Zou; Hui-Lin Zhang; Feng Peng; Zhao-Ji Liu; Wei-Hong Zheng; Jiang-Hua Yan; Li-Li Liu
Journal:  Springerplus       Date:  2016-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.